Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Opens New Euro Headquarters in Cambridge

This article has been updated from a previous version.

NEW YORK, July 19 - Accelrys today said it has opened its new European headquarters.

The new base, in Cambridge, UK, will consolidate staff from Accelrys' facilities already in that city as well as in Leeds and Oxford. These facilities will be shuttered when their staff finishes moving into the new space, scheduled to happen before the end of the quarter, according to an Accelrys spokesman.

According to Accelrys, a unit of drug discoverer Pharmacopoeia, the 42,000-square-foot space will be home to the company's European product-development staff, sales and marketing departments, finance, and administration.

Accelrys will also use a portion of the space to hold scientific conferences and seminars, the company said.

The spokesman, Jim Rivas, said their were no layoffs as a result of the move.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.